Kevin F Boehnke, PhD
Assistant Professor of Anesthesiology
[email protected]

Available to mentor
Kevin F Boehnke, PhD
Assistant Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a yoga instructor. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.

    Links
    • Departmental website
    Qualifications
    • Postdoctoral Fellowship
      University of Michigan, Anesthesiology, 2018
    • PhD
      University of Michigan, School of Public Health, 1415 Washington Heights, 2017
    • BS
      University of Michigan, Ann Arbor, 2009
    Research Overview

    • Public Health
    • Medical cannabis and cannabinoids
    • Chronic pain management
    • Yoga
    • Science communication and engagement
    • Psychedelics

    Recent Publications See All Publications
    • Journal Article
      Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.
      Bergmans RS, Wegryn-Jones R, Klida C, Kurtz V, Thomas L, Williams DA, Clauw DJ, Kidwell KM, Bohnert ASB, Boehnke KF. BMC Complement Med Ther, 2024 Jun 29; 24 (1): 250 DOI:10.1186/s12906-024-04558-3
      PMID: 38951902
    • Journal Article
      Cannabis-related information sources among US residents: A probability-weighted nationally representative survey.
      Boehnke KF, Smith T, Elliott MR, Wilson-Poe AR, Kruger DJ. J Cannabis Res, 2024 Oct 1; 6 (1): 38 DOI:10.1186/s42238-024-00249-5
      PMID: 39354586
    • Presentation
      Pragmatic Approaches to Chronic Pain and Cannabis Research in the Era of Cannabis Reform
      Boehnke K. 2024 Sep 26;
    • Journal Article
      Psychedelic therapist misconduct and other adverse events among a sample of naturalistic psychedelic users
      Aday JS, Glynos N, Boehnke KF, Barron J, Herberholz M, Kruger DJ.
    • Additional Scholarship
      CBG: Meet the Mother of All Cannabinoids
      Vilicic F. 2024 Aug 21;
    • Journal Article
      Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.
      Kruger DJ, Gerlach J, Kruger JS, Mokbel MA, Clauw DJ, Boehnke KF. Cannabis Cannabinoid Res, 2024 Aug; 9 (4): e1048 - e1055. DOI:10.1089/can.2022.0324
      PMID: 37098170
    • Preprint
      United States' qualifying conditions compared to evidence of the 2017 National Academy of Sciences Report.
      Stains EL, Kennalley AL, Tian M, Boehnke KF, Kraus CK, Piper BJ. 2024 Jul 10; DOI:10.1101/2023.05.01.23289286
      PMID: 37214833
    • Additional Scholarship
      Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
      Boehnke K. 2024 Jun 25;
    Featured News & Stories man practicing yoga outside over blanket
    Health Lab
    Reframing the role of medications in chronic pain management
    An expert on pain management discusses why relying on medications to ease discomfort can easily backfire, and how people can avoid complete reliance on these types of drugs.
         mushrooms in a microscope
    Health Lab
    How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
    Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
    Department News
    Daniel Clauw, M.D., and Kevin Boehnke, Ph.D., featured in New York Times opinion piece
    How can patients heal from chronic pain? Daniel Clauw, M.D., and Kevin Boehnke, Ph.D., provide insights in this New York Times opinion piece(link is external) from Nicholas Kristof.